Yuri E. Nikiforov, MD, PhD, Director of the Division of Molecular Anatomic Pathology, Department of Pathology, University of Pittsburgh, believes that one of the most exciting new developments in the treatment of thyroid cancer is the identification of novel oncogenes that can be applied to the management of patients with thyroid nodules.
No comments:
Post a Comment